ACTS
FIS Tactical Equity ETF
FIS Tactical Equity ETF seeks to achieve long-term capital appreciation by investing primarily in U.S. equities while employing a tactical investment strategy to adapt to market conditions.
US
EQUITY
Active
MANAGEMENT STYLE
$ 10.1 M
ASSETS UNDER MGMT
69 bp
EXPENSES
Fund Basics
| Inception date | Mar 18, 2026 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| VSE CORP | 4.7 % |
| BLOOM ENERGY CORPORATION CLASS A | 4.6 % |
| MONOLITHIC POWER SYSTEMS INC | 4.6 % |
| CASEY'S GENERAL STORES INC | 4.4 % |
| API GROUP CORPORATION | 4.1 % |
| FIRSTCASH, INC. | 4.0 % |
| INTERACTIVE BROKERS GRO-CL A | 3.8 % |
| IDEXX LABORATORIES INC | 3.7 % |
| TIM PARTICIPACOES S.A. SPONSORED ADR | 3.7 % |
| WEST PHARMACEUTICAL SERVICES | 3.6 % |
Constituent Breakdown
| Number of holdings | 35 |
| Herfindahl-Hirschman Index | 318 |
| Wgt avg mkt cap (mns) | $106,164 |
| Large cap (>$10bn) | 66.9% |
| Mid cap ($2-10bn) | 31.0% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 92.0% |
| Emerging mkts. | 5.9% |
Sector Breakdown
Country Exposure
| UNITED STATES | 85.0 % | |
| CANADA | 4.3 % | |
| BRAZIL | 3.7 % | |
| IRELAND | 2.7 % | |
| TAIWAN | 2.2 % |
Historical Performance
Standardized Performance (as of 10/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -- | -- | -- | -- | -- | -- | -- | -2.5% |
| Dividend Yield | -- | -- | -- | -- | -- | -- | -- | 0.0% |
| Total Returns | -- | -- | -- | -- | -- | -- | -- | -2.5% | Ann. Volatility | -- | -- | -- | -- | -- | -- | -- | 24.7% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.00 | 0% |
| MSCI EAFE | 0.00 | 0% |
| MSCI Emg Mkts | 0.00 | 0% |
Liquidity Measures
| Avg. volume (000) | 4 |
| ADV traded (mns) | $0 |
| Turnover | 1.0% |
| Avg. Bid/Ask (% of price) | 0.26% |
Technical Indicators
| 30d moving avg. (EMA) | $24.88 |
| Relative strength (RSI) | 47 |
| MACD/Signal | -0.18/-0.30 |
| Bollinger Bands (Upper/Lower) | $25.65/$23.44 |
| Short interest (% of AUM) | 0.2% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. ACTS |
Expenses vs. ACTS |
ALTAR Score™ vs. ACTS |
|---|---|---|---|---|
| KMID | Virtus KAR Mid-Cap ETF | 16.8% | +11 bp | -0.4% |
| PRAY | FIS Christian Stock Fund | 14.7% | 0 bp | -0.1% |
| GLRY | Inspire Faithward Mid Cap Momentum ETF | 14.5% | +18 bp | +1.0% |
| BASG | Brown Advisory Sustainable Growth ETF | 11.4% | -8 bp | -1.4% |
| RPG | Invesco S&P 500 Pure Growth ETF | 11.2% | -34 bp | -1.6% |
| FFOX | FundX Future Fund Opportunities ETF | 10.7% | +33 bp | -0.8% |
| QCLN | First Trust Nasdaq Clean Edge Green Energy Index Fund | 10.5% | -10 bp | -5.8% |
| BRIF | FIS Bright Portfolios Focused Equity ETF | 10.2% | -4 bp | +1.1% |
| IQM | Franklin Intelligent Machines ETF | 10.2% | -19 bp | -1.3% |
| KONG | Formidable Fortress ETF | 10.2% | +20 bp | +0.1% |
Risk and Returns: ACTS vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/18/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
4.8%
ALTAR SCORE™
34th
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,436 funds in the US Equity category with an average
ALTAR Score™ of 5.7% and a standard deviation
of 2.1%. ACTS's ALTAR Score™ is approximately -0.4 standard
deviations above the category average. This places ACTS in the 34th percentile
among funds in the category.
Sell-Side Consensus
$33.31
PRICE TARGET
+39.2%
UPSIDE